Bariatric surgery versus conventional medical therapy for type 2 diabetes - PubMed (original) (raw)
Randomized Controlled Trial
. 2012 Apr 26;366(17):1577-85.
doi: 10.1056/NEJMoa1200111. Epub 2012 Mar 26.
Affiliations
- PMID: 22449317
- DOI: 10.1056/NEJMoa1200111
Free article
Randomized Controlled Trial
Bariatric surgery versus conventional medical therapy for type 2 diabetes
Geltrude Mingrone et al. N Engl J Med. 2012.
Free article
Abstract
Background: Roux-en-Y gastric bypass and biliopancreatic diversion can markedly ameliorate diabetes in morbidly obese patients, often resulting in disease remission. Prospective, randomized trials comparing these procedures with medical therapy for the treatment of diabetes are needed.
Methods: In this single-center, nonblinded, randomized, controlled trial, 60 patients between the ages of 30 and 60 years with a body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) of 35 or more, a history of at least 5 years of diabetes, and a glycated hemoglobin level of 7.0% or more were randomly assigned to receive conventional medical therapy or undergo either gastric bypass or biliopancreatic diversion. The primary end point was the rate of diabetes remission at 2 years (defined as a fasting glucose level of <100 mg per deciliter [5.6 mmol per liter] and a glycated hemoglobin level of <6.5% in the absence of pharmacologic therapy).
Results: At 2 years, diabetes remission had occurred in no patients in the medical-therapy group versus 75% in the gastric-bypass group and 95% in the biliopancreatic-diversion group (P<0.001 for both comparisons). Age, sex, baseline BMI, duration of diabetes, and weight changes were not significant predictors of diabetes remission at 2 years or of improvement in glycemia at 1 and 3 months. At 2 years, the average baseline glycated hemoglobin level (8.65±1.45%) had decreased in all groups, but patients in the two surgical groups had the greatest degree of improvement (average glycated hemoglobin levels, 7.69±0.57% in the medical-therapy group, 6.35±1.42% in the gastric-bypass group, and 4.95±0.49% in the biliopancreatic-diversion group).
Conclusions: In severely obese patients with type 2 diabetes, bariatric surgery resulted in better glucose control than did medical therapy. Preoperative BMI and weight loss did not predict the improvement in hyperglycemia after these procedures. (Funded by Catholic University of Rome; ClinicalTrials.gov number, NCT00888836.).
Comment in
- Surgery or medical therapy for obese patients with type 2 diabetes?
Zimmet P, Alberti KG. Zimmet P, et al. N Engl J Med. 2012 Apr 26;366(17):1635-6. doi: 10.1056/NEJMe1202443. Epub 2012 Mar 26. N Engl J Med. 2012. PMID: 22449318 No abstract available. - Diabetes: On trial--bariatric surgery for treatment of type 2 diabetes mellitus.
Osório J. Osório J. Nat Rev Endocrinol. 2012 Apr 10;8(6):317. doi: 10.1038/nrendo.2012.57. Nat Rev Endocrinol. 2012. PMID: 22488643 No abstract available. - ACP Journal Club. Gastric bypass or biliopancreatic diversion increases remission from type 2 diabetes in obese adults.
Pokala S. Pokala S. Ann Intern Med. 2012 Jul 17;157(2):JC2-12. doi: 10.7326/0003-4819-157-2-201207170-02012. Ann Intern Med. 2012. PMID: 22801703 No abstract available. - Bariatric surgery or medical therapy for obesity.
Gletsu-Miller N, Ziegler TR. Gletsu-Miller N, et al. N Engl J Med. 2012 Aug 2;367(5):473; author reply 474-6. doi: 10.1056/NEJMc1206633. N Engl J Med. 2012. PMID: 22853019 No abstract available. - Bariatric surgery or medical therapy for obesity.
Frontoni S, Malandrucco I, Bonadonna RC. Frontoni S, et al. N Engl J Med. 2012 Aug 2;367(5):473-4; author reply 474-6. doi: 10.1056/NEJMc1206633. N Engl J Med. 2012. PMID: 22853020 No abstract available. - Bariatric surgery or medicine for type 2 diabetes?
Doggrell SA, Chan V. Doggrell SA, et al. Expert Opin Pharmacother. 2012 Oct;13(15):2249-53. doi: 10.1517/14656566.2012.721779. Epub 2012 Sep 8. Expert Opin Pharmacother. 2012. PMID: 22957791 - [Bariatric surgery versus conventional medical therapy for type 2 diabetes].
Gómez-Huelgas R. Gómez-Huelgas R. Rev Clin Esp. 2012 Oct;212(9):461. doi: 10.1016/j.rce.2012.05.020. Rev Clin Esp. 2012. PMID: 23213657 Spanish. No abstract available. - An obesity remedy for diabetes.
Neutze D, Egan M, Mounsey A. Neutze D, et al. J Fam Pract. 2013 Jan;62(1):30-2. J Fam Pract. 2013. PMID: 23326820 Free PMC article. - The surgical cure for diabetes?
Simha V, Shah P. Simha V, et al. Natl Med J India. 2012 Sep-Oct;25(5):281-3. Natl Med J India. 2012. PMID: 23448628 No abstract available. - [Bariatric surgery and diabetes mellitus: pioneering studies from 2012 and consequences for treatment strategies].
Scherbaum WA, Nitschmann S. Scherbaum WA, et al. Internist (Berl). 2013 May;54(5):639-44. doi: 10.1007/s00108-013-3274-z. Internist (Berl). 2013. PMID: 23568061 German. No abstract available. - Update in endocrinology: evidence published in 2012.
Schlechte JA. Schlechte JA. Ann Intern Med. 2013 Jun 4;158(11):821-4. doi: 10.7326/0003-4819-158-11-201306040-00106. Ann Intern Med. 2013. PMID: 23580066 No abstract available.
Similar articles
- Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.
Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G, Castagneto M, Bornstein S, Rubino F. Mingrone G, et al. Lancet. 2015 Sep 5;386(9997):964-73. doi: 10.1016/S0140-6736(15)00075-6. Lancet. 2015. PMID: 26369473 Clinical Trial. - Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.
Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, Navaneethan SD, Singh RP, Pothier CE, Nissen SE, Kashyap SR; STAMPEDE Investigators. Schauer PR, et al. N Engl J Med. 2017 Feb 16;376(7):641-651. doi: 10.1056/NEJMoa1600869. N Engl J Med. 2017. PMID: 28199805 Free PMC article. Clinical Trial. - Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.
Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ES, Nissen SE, Kashyap SR; STAMPEDE Investigators. Schauer PR, et al. N Engl J Med. 2014 May 22;370(21):2002-13. doi: 10.1056/NEJMoa1401329. Epub 2014 Mar 31. N Engl J Med. 2014. PMID: 24679060 Free PMC article. Clinical Trial. - Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis.
Panunzi S, De Gaetano A, Carnicelli A, Mingrone G. Panunzi S, et al. Ann Surg. 2015 Mar;261(3):459-67. doi: 10.1097/SLA.0000000000000863. Ann Surg. 2015. PMID: 25361217 Review. - Surgery for weight loss in adults.
Colquitt JL, Pickett K, Loveman E, Frampton GK. Colquitt JL, et al. Cochrane Database Syst Rev. 2014 Aug 8;2014(8):CD003641. doi: 10.1002/14651858.CD003641.pub4. Cochrane Database Syst Rev. 2014. PMID: 25105982 Free PMC article. Review.
Cited by
- Relationship between Body Adiposity Indices and Reversal of Metabolically Unhealthy Obesity 6 Months after Roux-en-Y Gastric Bypass.
Luna M, Pereira S, Saboya C, Ramalho A. Luna M, et al. Metabolites. 2024 Sep 18;14(9):502. doi: 10.3390/metabo14090502. Metabolites. 2024. PMID: 39330509 Free PMC article. - Analysis of long-term outcome of modified gastric bypass for type 2 diabetes mellitus in Chinese patients.
Xing Y, Bai RX, Li YG, Xu J, Zhong ZQ, Yan M, Yan WM. Xing Y, et al. World J Clin Cases. 2024 Sep 6;12(25):5697-5705. doi: 10.12998/wjcc.v12.i25.5697. World J Clin Cases. 2024. PMID: 39247739 Free PMC article. - Prioritising patients for publicly funded bariatric surgery in Queensland, Australia.
Scuffham P, Cross M, Teppala S, Hopkins G, Chikani V, Wykes K, Paxton J. Scuffham P, et al. Int J Obes (Lond). 2024 Aug 22. doi: 10.1038/s41366-024-01615-2. Online ahead of print. Int J Obes (Lond). 2024. PMID: 39174748 - Changes in use and hospital outcomes of bariatric surgery in Spain (2016-2022): analysis of the role of type 2 diabetes using propensity score matching.
Lopez-de-Andres A, Jimenez-Garcia R, Cuadrado-Corrales N, Carabantes-Alarcon D, Hernandez-Barrera V, de Miguel-Diez J, Jimenez-Sierra A, Zamorano-Leon JJ. Lopez-de-Andres A, et al. BMJ Open Diabetes Res Care. 2024 Aug 3;12(4):e004351. doi: 10.1136/bmjdrc-2024-004351. BMJ Open Diabetes Res Care. 2024. PMID: 39097299 Free PMC article. - Alterations in bile acid kinetics after bariatric surgery in patients with obesity with or without type 2 diabetes.
Wahlström A, Aydin Ö, Olsson LM, Sjöland W, Henricsson M, Lundqvist A, Marschall HU, Franken R, van de Laar A, Gerdes V, Meijnikman AS, Hofsø D, Groen AK, Hjelmesæth J, Nieuwdorp M, Bäckhed F. Wahlström A, et al. EBioMedicine. 2024 Aug;106:105265. doi: 10.1016/j.ebiom.2024.105265. Epub 2024 Aug 2. EBioMedicine. 2024. PMID: 39096744 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials